Katarina Uttervall - Search Results

Year	Number of Results
2013	3
2014	3
2015	1
2017	1
2019	2
2021	3
2022	2
2023	2
2024	2

1

Response to Caravita di Toritto and Rago.

Chaireti R, Uttervall K, Luong V, Lund J, Kashif M, Gahrton G, Alici E, Nahi H, Afram G. Chaireti R, et al. Among authors: uttervall k. Eur J Haematol. 2023 Feb;110(2):224-225. doi: 10.1111/ejh.13887. Epub 2022 Nov 7. Eur J Haematol. 2023. PMID: 36300846 No abstract available.

2

Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.

Nahi H, Afram G, Uttervall K, Lockmer S, Tätting L, Gahrton G, Kashif M, Alici E, Stromberg O, Klimkowska M, Lund J. Nahi H, et al. Among authors: uttervall k. Cancer Med. 2023 Nov;12(22):20736-20744. doi: 10.1002/cam4.6640. Epub 2023 Nov 3. Cancer Med. 2023. PMID: 37921243 Free PMC article.

3

Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14).

Nahi H, Kashif M, Klimkowska M, Karvouni M, Wallblom A, Gran C, Hauenstein J, Frengen N, Gustafsson C, Afram G, Uttervall K, Lund J, Månsson R, Wagner AK, Alici E. Nahi H, et al. Among authors: uttervall k. Am J Hematol. 2021 Aug 1;96(8):925-933. doi: 10.1002/ajh.26207. Epub 2021 May 18. Am J Hematol. 2021. PMID: 33901326 Free article.

4

Antibody response to COVID-19 mRNA vaccine (Comirnaty) in myeloma patients treated with high-dose melphalan and/or immunotherapy.

Lockmer S, Uttervall K, Kashif M, Svärd C, Malmsten K, Fletcher-Torres E, Alici E, Lund J, Nahi H. Lockmer S, et al. Among authors: uttervall k. Am J Hematol. 2021 Nov 1;96(11):E443-E446. doi: 10.1002/ajh.26348. Epub 2021 Sep 22. Am J Hematol. 2021. PMID: 34524709 Free PMC article. No abstract available.

5

Conditioning with melphalan 200 mg/m² and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.

Afram G, Chaireti R, Uttervall K, Luong V, Lund J, Kashif M, Gahrton G, Alici E, Nahi H. Afram G, et al. Among authors: uttervall k. Eur J Haematol. 2022 Dec;109(6):749-754. doi: 10.1111/ejh.13861. Epub 2022 Sep 20. Eur J Haematol. 2022. PMID: 36066204 Free PMC article.

6

Effectiveness and infectious complications of BCMA T-cell engagers in treating multiple myeloma: Real-world evidence from Sweden.

Uttervall K, Tätting L, Lemonakis K, Majd M, Crafoord J, Olsson M, Mellqvist UH, Hansson M, Nahi H. Uttervall K, et al. Cancer Med. 2024 Apr;13(8):e7048. doi: 10.1002/cam4.7048. Cancer Med. 2024. PMID: 38651177 Free PMC article.

7

Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.

Afram G, Susek KH, Uttervall K, Wersäll JD, Wagner AK, Luong V, Lund J, Gahrton G, Alici E, Nahi H. Afram G, et al. Among authors: uttervall k. Eur J Haematol. 2021 Apr;106(4):546-554. doi: 10.1111/ejh.13585. Epub 2021 Feb 2. Eur J Haematol. 2021. PMID: 33471414

8

Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?

Gran C, Uttervall K, Borg Bruchfeld J, Wallblom A, Alici E, Gahrton G, Nahi H. Gran C, et al. Among authors: uttervall k. Eur J Haematol. 2019 Dec;103(6):588-596. doi: 10.1111/ejh.13325. Epub 2019 Oct 6. Eur J Haematol. 2019. PMID: 31487754 Clinical Trial.

9

Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma.

Uttervall K, Borg Bruchfeld J, Gran C, Wålinder G, Månsson R, Lund J, Gahrton G, Alici E, Nahi H. Uttervall K, et al. Eur J Haematol. 2019 Sep;103(3):247-254. doi: 10.1111/ejh.13280. Epub 2019 Jul 7. Eur J Haematol. 2019. PMID: 31231833

10

Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register.

Nahi H, Genell A, Wålinder G, Uttervall K, Juliusson G, Karin F, Hansson M, Svensson R, Linder O, Carlson K, Björkstrand B, Kristinsson SY, Mellqvist UH, Blimark C, Turesson I. Nahi H, et al. Among authors: uttervall k. Eur J Haematol. 2017 Sep;99(3):216-222. doi: 10.1111/ejh.12907. Epub 2017 Jun 28. Eur J Haematol. 2017. PMID: 28544116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year